Trials / Conditions / Primitive Neuroectodermal Tumor

Primitive Neuroectodermal Tumor

9 registered clinical trials studyying Primitive Neuroectodermal Tumor — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Agnostic Therapy in Rare Solid Tumors NCT06638931	Instituto do Cancer do Estado de São Paulo	Phase 2
Withdrawn	Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer NCT04521946	M.D. Anderson Cancer Center	Phase 1
Recruiting	Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Mid NCT04185038	Seattle Children's Hospital	Phase 1
Completed	EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS NCT03638167	Seattle Children's Hospital	Phase 1
Active Not Recruiting	HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumor NCT03500991	Seattle Children's Hospital	Phase 1
Completed	SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies fo NCT03434262	St. Jude Children's Research Hospital	Phase 1
Recruiting	Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and S NCT02508038	University of Wisconsin, Madison	Phase 1
Unknown	Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CN NCT00983398	OHSU Knight Cancer Institute	Phase 1 / Phase 2
Terminated	Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectoderma NCT00003515	Burzynski Research Institute	Phase 2